LIPOCINE INC. Current Assets
LIPOCINE INC. (LPCN) had Current Assets of $23.74 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-04
- 2026-06-30: Assets, Current $23.74M.
- 2026-03-31: Assets, Current $25.24M.
- 2025-12-31: Assets, Current $16.88M.
- 2025-09-30: Assets, Current $15.93M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $23.74M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $25.24M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $16.88M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $15.93M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $18.42M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $20.33M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $22.32M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $20.50M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $22.91M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $25.32M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $22.86M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $24.61M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $27.08M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $30.61M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $34.14M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $36.11M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $38.08M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $43.50M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $46.38M 10-K · filed 2023-03-10 | |
| 2021-09-30 | $40.37M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $47.16M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $45.94M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $25.33M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $24.73M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $23.46M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $20.97M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $19.63M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $17.31M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $19.64M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $22.95M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $20.81M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $22.64M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $25.25M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $31.62M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $25.22M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $26.14M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $27.93M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $27.10M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $27.21M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $29.41M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $33.20M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $38.64M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $44.88M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $42.29M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $44.15M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $24.95M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $27.90M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $31.95M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $35.44M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $42.03M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $46.03M 10-K · filed 2015-03-11 | |
| 2013-09-30 | $37.09M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $10.00 10-Q · filed 2013-07-09 | |
| 2013-03-31 | $458.00 10-Q · filed 2013-04-24 | |
| 2012-12-31 | $5.47M 10-K · filed 2014-03-31 | $577.00 10-K · filed 2013-02-26 |
| 2012-09-30 | $622.00 10-Q · filed 2012-10-26 | |
| 2011-12-31 | $32.44K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |